AGRINFO AGRINFO logo

THE LATEST ON EU AGRI-FOOD POLICIES IMPACTING LOW- AND MIDDLE-INCOME COUNTRIES

Latest novel food authorisations, amendments, and extensions 2024

Summary

This report summarises recent EU decisions to authorise, amend, or extend the specifications or conditions of use of existing novel foods:

  • 2'-FL obtained by microbial fermentation using a derivative strain of Escherichia coli by Kyowa Hakko Bio Co.
  • LNFP-I/2'-FL mixture obtained by microbial fermentation using a derivative strain of E. coli
  • Schizochytrium limacinum (TKD-1) oil
  • Schizochytrium sp. (CABIO-A-2) oil
  • Ashitaba stem juice.

The EU has authorised the following changes:

  • extension of use of the novel food Yarrowia lipolytica yeast biomass to meal replacements for weight control intended for the adult population
  • labelling requirements ‘Partially hydrolysed protein from barley and rice’ for foods containing partially hydrolysed protein from spent barley and rice
  • specifications and conditions of use of protein extract from pig kidneys will only refer to the maximum authorised levels; its different forms are removed from the specifications
  • lower levels of docosahexaenoic acid (DHA) in specifications of the novel food Schizochytrium sp. oil rich in DHA and eicosapentaenoic acid (EPA)
  • authorised levels of 2'-FL will increase from current levels authorised in both infant formulae and follow-on formulae
  • authorised levels of residual endotoxins for 2'-FL produced from derivative strain E. coli BL-21 will be aligned to levels already authorised under the same conditions of use for 2'-FL from E. coli K-12, and other milk oligosaccharides at similar residual levels in infant formulae and follow-on formulae.